Prevalence of atrial fibrillation and relation to echocardiographic parameters in a healthy asymptomatic rural Korean population

Journal of Korean Medical Science

Volumn 30, Issue 8, 2015, Pages 1078-1084

  Park, Hwan Cheol ^a   Park, Jin Kyu ^b   Choi, Sung Il ^a   Kim, Soon Gil ^a   Kim, Mi Kyung ^c   Choi, Bo Youl ^c   Shin, Jinho ^b  

^a Hanyang University Guri Hospital   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Atrial fibrillation; Community based cohort; Echocardiography; Electrocardiography; Prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SEX RATIO; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; STROKE; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; RISK FACTORS; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STROKE; STROKE VOLUME;

EID: 84951758218     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2015.30.8.1078     Document Type: Article

References (29)

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-25.
2. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011; 13: 1110-7.
3. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001; 86: 284-8.
4. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
5. Ohsawa M, Okayama A, Sakata K, Kato K, Itai K, Onoda T, Ueshima H. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol 2005; 15: 194-6.
6. Yap KB, Ng TP, Ong HY. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. J Electrocardiol 2008; 41: 94-8.
7. Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005; 20: 26-30.
8. Lim YH, Kim YM, Shin J, Lee CH, Kim JH, Kim MK, Choi BY. Association of heart rate and left ventricular structure in a rural population in Korea. Clin Exp Hypertens 2014; 36: 165-72.
9. Nicol MB, Thrift AG. Knowledge of risk factors and warning signs of stroke. Vasc Health Risk Manag 2005; 1: 137-47.
10. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 2012; 109: 293-9.
11. Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJ. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007; 93: 606-12.
12. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-53.
13. Langenberg M, Hellemons BS, van Ree JW, Vermeer F, Lodder J, Schouten HJ, Knottnerus JA. Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice. BMJ 1996; 313: 1534.
14. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart 1998; 79: 50-5.
15. Djoussé L, Levy D, Benjamin EJ, Blease SJ, Russ A, Larson MG, Massaro JM, D'Agostino RB, Wolf PA, Ellison RC. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004; 93: 710-3.
16. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-73.
17. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-7.
18. Brønnum-Hansen H, Jørgensen T, Davidsen M, Madsen M, Osler M, Gerdes LU, Schroll M. Survival and cause of death after myocardial infarction: the Danish MONICA study. J Clin Epidemiol 2001; 54: 1244-50.
19. Capewell S, Livingston BM, MacIntyre K, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, Evans CJ, McMurray JJ. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000; 21: 1833-40.
20. Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, Oikawa Y, Koike A, Nagashima K, Kirigaya H, et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012; 76: 607-11.
21. Sinner MF, Wang N, Fox CS, Fontes JD, Rienstra M, Magnani JW, Vasan RS, Calderwood AH, Pencina M, Sullivan LM, et al. Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol 2013; 111: 219-24.
22. Iguchi Y, Kimura K, Kobayashi K, Aoki J, Terasawa Y, Sakai K, Uemura J, Shibazaki K. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 2008; 102: 1056-9.
23. Rienstra M, Sun JX, Lubitz SA, Frankel DS, Vasan RS, Levy D, Magnani JW, Sullivan LM, Meigs JB, Ellinor PT, et al. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J 2012; 163: 119-24.e1.
24. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-4.
25. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902.
26. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 2008; 79: 279-86.
27. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-4.
28. Weikert C, Westphal S, Berger K, Dierkes J, Möhlig M, Spranger J, Rimm EB, Willich SN, Boeing H, Pischon T. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 2008; 93: 2647-53.
29. Shimano M, Shibata R, Tsuji Y, Kamiya H, Uchikawa T, Harata S, Muto M, Ouchi N, Inden Y, Murohara T. Circulating adiponectin levels in patients with atrial fibrillation. Circ J 2008; 72: 1120-4.